FilingReader Intelligence
Huahai Pharma adjusts convertible bond conversion price post equity distribution
July 2, 2025 at 05:11 AM UTC•By FilingReader AI
Zhejiang Huahai Pharmaceutical (SSE:600521) announced that it will adjust the conversion price of its "Huahai Convertible Bonds" from CNY 33.31 per share to CNY 33.06 per share, effective July 10, 2025. This adjustment follows the company's implementation of its 2024 annual equity distribution plan, approved at the shareholder's meeting on May 23, 2025, where shareholders of record on July 9, 2025 will receive a cash dividend of CNY 0.25 per share.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
News Alerts
Get instant email alerts when Zhejiang Huahai Pharmaceutical publishes news
Free account required • Unsubscribe anytime